AHI Viewpoint
AHI Statement from Martha Scott Poindexter on Presidential Proclamation of Pharmaceutical Tariffs
April 6, 2026—The Animal Health Institute today expressed appreciation to the Trump Administration for recognizing the value of animal health products in the Proclamation entitled “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States” released on April 2, 2026. “While we are still analyzing the Proclamation we look forward to working with the […]
AHI Welcomes Dr. Ellen J. Hart as Vice President of Regulatory and International Affairs
Washington, D.C. — April 6, 2026 — The Animal Health Institute (AHI) today announced that Ellen J. Hart, DVM, has joined the organization as Vice President of Regulatory and International Affairs. In her role, Dr. Hart will lead the industry’s regulatory reform effort, coordinate industry’s efforts in anticipation of the Animal Drug User Fee Act […]
Statement from AHI on the Final Guidance from FDA’s Center for Veterinary Medicine on the Duration of Use of Antimicrobials
The Animal Health Institute today applauded the final guidance published by FDA’s Center for Veterinary Medicine (CVM) on the duration of use of antimicrobials. The guidance establishes a framework for sponsors to work with CVM to determine appropriate limits of use for medically important antimicrobials in feed and water while maintaining the ability of licensed […]
AHI Applauds Confirmation of Julie Callahan as Chief Agricultural Negotiator for USTR
(December 19, 2025) Martha Scott Poindexter, President and CEO of the Animal Health Institute, today welcomed the Senate Confirmation of Dr. Julie Callahan as Chief Agricultural Negotiator for the Office of U.S. Trade Representative. “We are thrilled with Julie’s appointment and thank the Senate for acting to confirm her,” said Poindexter. “At a time when […]















